Publications by authors named "Matt Labenski"

Claim this Profile
A
A Chemoproteomics Approach to Determine the Mechanism of Testicular Toxicity for the Bruton's Tyrosine Kinase Inhibitor CC-292.
Matt Labenski, Lukas Voortman, Aravind Prasad Medikonda, Philip J Sherratt, Alan F Corin

J Pharmacol Exp Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS-Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance.
Ida Aronchik, Yumin Dai, Matt Labenski, Carmen Barnes, Terri Jones

Mol Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis